Buscar
-
Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
(Drug Safety. vol. 43, n° 11, pp. 1105-1120, 2020)Article de revueLibre acceso -
Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France
(Clinical Therapeutics. vol. 42, n° 10, pp. 1983-1991 e2, 2020)Article de revueLibre acceso -
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
(Lancet Diabetes and Endocrinology. vol. 8, n° 5, pp. 365-367, 2020)Article de revue -
Severe Adverse Events during Medical and Surgical Treatment of Hip and Knee Prosthetic Joint Infections
(Médecine et Maladies Infectieuses, 2020-10-20)Article de revue -
International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium
(npj Digital Medicine. vol. 3, pp. 109, 2020)Article de revueLibre acceso -
Impact of pregnancy on antidepressant treatment course: a population-based comparative cohort study in France
(Archives of Women's Mental Health. vol. 23, n° 5, pp. 699-707, 2020)Article de revue -
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score Strategies
(Drug Safety. vol. 43, n° 6, pp. 549-559, 2020)Article de revue -
Pharmaceutical market of analgesic medicines in Romania
(Farmacia. vol. 68, n° 5, pp. 938-943, 2020)Article de revue -
The Burden of Potentially Inappropriate Medications in Chronic Polypharmacy
(Journal of Clinical Medicine. vol. 9, n° 11, pp. 3728, 2020-11-20)Article de revueLibre acceso -
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database
(Drug Safety. vol. 43, n° 3, pp. 243-253, 2020)Article de revue